Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 1863 entries
View as:

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT07006506 Org: User:
Start: 05/21/25 End: 05/21/29 Due: 05/21/30

The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05458284 Org: User:
Start: 07/11/22 End: 07/31/25 Due: 07/31/26

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01419834 Org: User:
Start: 08/15/11 End: 08/02/23 Due: 08/02/24

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00474994 Org: User:
Start: 04/30/07 End: 11/30/10 Due: 11/30/11

Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

Phase: N/A Priority: Normal
NCT ID: NCT02494882 Org: User:
Start: 06/29/15 End: 06/30/25 Due: 06/30/26

Study of Abemaciclib in Dedifferentiated Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02846987 Org: User:
Start: 07/31/16 End: 07/31/26 Due: 07/31/27

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02131805 Org: User:
Start: 05/31/14 End: 05/31/26 Due: 05/31/27

Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00911560 Org: User:
Start: 05/27/09 End: 05/31/26 Due: 05/31/27

A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06903702 Org: User:
Start: 06/04/25 End: 06/30/27 Due: 06/30/28

A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03542175 Org: User:
Start: 05/23/18 End: 07/25/25 Due: 07/25/26

A Randomized Study of Sulindac in Oral Premalignant Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00299195 Org: User:
Start: 02/23/06 End: 01/06/20 Due: 01/06/21

Men Undergoing Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00582530 Org: User:
Start: 12/28/04 End: 06/21/22 Due: 06/21/23

Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01589094 Org: User:
Start: 04/30/12 End: 08/31/18 Due: 08/31/19

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00052429 Org: User:
Start: 09/30/02 End: 11/30/10 Due: 11/30/11

A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

Phase: N/A Priority: Normal
NCT ID: NCT02772575 Org: User:
Start: 04/30/16 End: - Due: -

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Phase: N/A Priority: Normal
NCT ID: NCT00005860 Org: User:
Start: 04/30/00 End: - Due: -

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01248962 Org: User:
Start: 11/30/10 End: 08/31/18 Due: 08/31/19

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04019327 Org: User:
Start: 07/11/19 End: 07/31/27 Due: 07/31/28

Registry for Patients with Erdheim-Chester Disease and Other Histiocytoses

Phase: N/A Priority: Normal
NCT ID: NCT03329274 Org: User:
Start: 10/26/17 End: 10/31/25 Due: 10/31/26

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03879811 Org: User:
Start: 03/13/19 End: 03/31/21 Due: 03/31/22

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003025 Org: User:
Start: 03/31/97 End: 07/31/02 Due: 07/31/03

Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT00739141 Org: User:
Start: 08/12/08 End: 10/15/21 Due: 10/15/22

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03334708 Org: User:
Start: 10/30/17 End: 10/30/25 Due: 10/30/26

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01491698 Org: User:
Start: 12/31/11 End: 08/31/13 Due: 08/31/14

Psychostimulants for Fatigue in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00138138 Org: User:
Start: 10/31/02 End: 08/31/06 Due: 08/31/07